Related references
Note: Only part of the references are listed.Extrahepatic autoimmune diseases in primary biliary cholangitis: Prevalence and significance for clinical presentation and disease outcome
Cumali Efe et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)
Primary biliary cholangitis with normal alkaline phosphatase: A neglected clinical entity challenging current guidelines
Benedetta Terziroli Beretta-Piccoli et al.
JOURNAL OF AUTOIMMUNITY (2021)
IgM response is a prognostic biomarker of primary biliary cholangitis treated with ursodeoxycholic acid and bezafibrate
Keiko Takano et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)
Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases
Keith D. Lindor et al.
HEPATOLOGY (2019)
Histologically proven AMA positive primary biliary cholangitis but normal serum alkaline phosphatase: Is alkaline phosphatase truly a surrogate marker?
Chunyan Sun et al.
JOURNAL OF AUTOIMMUNITY (2019)
Large-Scale Characterization Study of Patients With Antimitochondrial Antibodies but Nonestablished Primary Biliary Cholangitis
Geraldine Dahlqvist et al.
HEPATOLOGY (2017)
Positive antimitochondrial antibody but normal serum alkaline phosphatase levels: Could it be primary biliary cholangitis?
Tania Berdichevski et al.
HEPATOLOGY RESEARCH (2017)
EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis
Gideon M. Hirschfield et al.
JOURNAL OF HEPATOLOGY (2017)
The UK-PBC Risk Scores: Derivation and Validation of a Scoring System for Long-Term Prediction of End-Stage Liver Disease in Primary Biliary Cholangitis
Marco Carbone et al.
HEPATOLOGY (2016)
Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy
Willem J. Lammers et al.
GASTROENTEROLOGY (2015)
Changing nomenclature for PBC: From cirrhosis' to cholangitis'
Ulrich Beuers et al.
HEPATOLOGY (2015)
Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis
Ana Lleo et al.
HEPATOLOGY (2012)
Primary Biliary Cirrhosis
Keith D. Lindor et al.
HEPATOLOGY (2009)
Ursodeoxycholic acid reduces CpG-induced IgM production in patients with primary biliary cirrhosis
Kentaro Kikuchi et al.
HEPATOLOGY RESEARCH (2009)
Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis
Christophe Corpechot et al.
HEPATOLOGY (2008)
Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosis
Konstantims N. Lazaridis et al.
HEPATOLOGY (2007)
Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid
A Parés et al.
GASTROENTEROLOGY (2006)
Risk factors and comorbidities in primary biliary cirrhosis: A controlled interview-based study of 1032 patients
ME Gershwin et al.
HEPATOLOGY (2005)
Share Paper
